These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25034793)

  • 1. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients.
    Koval CE; Thuita L; Moazami N; Blackstone E
    J Heart Lung Transplant; 2014 Nov; 33(11):1164-72. PubMed ID: 25034793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation.
    Martin BJ; Luc JGY; Maruyama M; MacArthur R; Bates AR; Buchholz H; Freed DH; Conway J
    ASAIO J; 2018; 64(5):616-622. PubMed ID: 29035899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Durand ML; Ennis SC; Baker JN; Camuso JM; McEachern KM; Kotton CN; Lewis GD; Garcia JP; MacGillivray TE
    Artif Organs; 2017 Feb; 41(2):169-175. PubMed ID: 27098102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing driveline infections in patients supported on ventricular assist devices: a care pathway approach.
    Seretny J; Pidborochynski T; Buchholz H; Freed DH; MacArthur R; Dubyk N; Cunliffe L; Zelaya O; Conway J
    BMJ Open Qual; 2022 May; 11(2):. PubMed ID: 35649636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center.
    Hamad Y; Blanco-Guzman MO; Olsen MA; Wang X; Vader J; Verma A; Dubberke ER
    Transpl Infect Dis; 2021 Aug; 23(4):e13686. PubMed ID: 34251073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driveline infections in left ventricular assist devices: implications for destination therapy.
    Sharma V; Deo SV; Stulak JM; Durham LA; Daly RC; Park SJ; Baddour LM; Mehra K; Joyce LD
    Ann Thorac Surg; 2012 Nov; 94(5):1381-6. PubMed ID: 22818961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device-related infection: treatment and outcome.
    Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
    Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents.
    Trachtenberg BH; Cordero-Reyes AM; Aldeiri M; Alvarez P; Bhimaraj A; Ashrith G; Elias B; Suarez EE; Bruckner B; Loebe M; Harris RL; Zhang JY; Torre-Amione G; Estep JD
    J Card Fail; 2015 Feb; 21(2):119-25. PubMed ID: 25463739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Driveline Infection in Patients With Left Ventricular Assist Devices Implanted as Destination Therapy.
    Wasilewski G; Wiśniowska-Śmiałek S; Górkiewicz-Kot I; Milaniak I; Kaleta M; Hymczak H; Wasilewska A; Wierzbicki K
    Transplant Proc; 2024 May; 56(4):860-863. PubMed ID: 38734518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Related to the Severity of Early Postoperative Infection After Heart Transplantation in Patients Surviving Prolonged Mechanical Support Periods: Experience at a Single University.
    Abe R; Shibata SC; Saito S; Tsukamoto Y; Toda K; Uchiyama A; Sakata Y; Sawa Y; Tomono K; Fujino Y
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):53-59. PubMed ID: 29229257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy.
    Kamat I; Lamba H; Hines-Munson C; Hudson S; Liao K; Muldrew KL; Green S; Terwilliger A; Kaplan HB; Ramig RF; Maresso A; Trautner BW
    J Surg Res; 2022 Mar; 271():73-81. PubMed ID: 34847492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994.
    Holman WL; Murrah CP; Ferguson ER; Bourge RC; McGiffin DC; Kirklin JK
    Ann Thorac Surg; 1996 Jan; 61(1):366-71; discussion 372-3. PubMed ID: 8561607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
    Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
    J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.